Clinical trial
Beta-lactam Monotherapy Versus Beta-lactam - Macrolide Association as Empiric Antibiotherapy Strategies in Non-severe Hospitalized Community-acquired Pneumonia: a Randomized, Non-inferiority, Open Trial.
NCT00818610 is registered in ClinicalTrials.gov with Swiss National Fund for Scientific Research as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Beta-lactam Monotherapy Versus Beta-lactam - Macrolide Association as Empiric Antibiotherapy Strategies in Non-severe Hospitalized Community-acquired Pneumonia: a Randomized, Non-inferiority, Open Trial.
- Lead sponsor
- Swiss National Fund for Scientific Research
- Phase
- Phase 4
- Overall status
- Completed
- Start date
- January 31, 2009
- Completion date
- April 30, 2013
- Enrollment
- 601 (actual)
- Sites
- 6
Conditions
As the registry lists them; a condition with its own page is linked.